Allurion Technologies (NYSE:ALUR) Announces Quarterly Earnings Results

Allurion Technologies (NYSE:ALURGet Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.11 EPS for the quarter, Zacks reports. The firm had revenue of $9.39 million for the quarter. Allurion Technologies updated its FY 2024 guidance to EPS.

Allurion Technologies Stock Down 9.0 %

NYSE ALUR traded down $0.19 during mid-day trading on Wednesday, hitting $1.92. The stock had a trading volume of 128,196 shares, compared to its average volume of 695,762. The firm’s 50 day moving average is $2.18 and its 200 day moving average is $3.02. Allurion Technologies has a twelve month low of $1.56 and a twelve month high of $9.00.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on ALUR shares. Chardan Capital reiterated a “buy” rating and set a $5.00 target price on shares of Allurion Technologies in a research report on Wednesday. Jefferies Financial Group assumed coverage on Allurion Technologies in a research report on Friday, February 9th. They set a “buy” rating and a $5.00 target price for the company.

Get Our Latest Analysis on ALUR

Allurion Technologies Company Profile

(Get Free Report)

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

Featured Articles

Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.